130 related articles for article (PubMed ID: 29329326)
1. Utilization of peptide phage display to investigate hotspots on IL-17A and what it means for drug discovery.
Ting JP; Tung F; Antonysamy S; Wasserman S; Jones SB; Zhang FF; Espada A; Broughton H; Chalmers MJ; Woodman ME; Bina HA; Dodge JA; Benach J; Zhang A; Groshong C; Manglicmot D; Russell M; Afshar S
PLoS One; 2018; 13(1):e0190850. PubMed ID: 29329326
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures of interleukin 17A and its complex with IL-17 receptor A.
Liu S; Song X; Chrunyk BA; Shanker S; Hoth LR; Marr ES; Griffor MC
Nat Commun; 2013; 4():1888. PubMed ID: 23695682
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting complex IL-17A and IL-17RA interactions with a linear peptide.
Liu S; Desharnais J; Sahasrabudhe PV; Jin P; Li W; Oates BD; Shanker S; Banker ME; Chrunyk BA; Song X; Feng X; Griffor M; Jimenez J; Chen G; Tumelty D; Bhat A; Bradshaw CW; Woodnutt G; Lappe RW; Thorarensen A; Qiu X; Withka JM; Wood LD
Sci Rep; 2016 May; 6():26071. PubMed ID: 27184415
[TBL] [Abstract][Full Text] [Related]
4. An Overview of Interleukin-17A and Interleukin-17 Receptor A Structure, Interaction and Signaling.
Krstic J; Obradovic H; Kukolj T; Mojsilovic S; Okic-Dordevic I; Bugarski D; Santibanez JF
Protein Pept Lett; 2015; 22(7):570-8. PubMed ID: 25990083
[TBL] [Abstract][Full Text] [Related]
5. Molecular modeling and rational design of disulfide-stapled self-inhibitory peptides to target IL-17A/IL-17RA interaction.
Huang W; Zhou Y; Pan C; Zhang X; Zhao H; Shen L
J Mol Recognit; 2023 Aug; 36(8):e3045. PubMed ID: 37415317
[TBL] [Abstract][Full Text] [Related]
6. Structural Analysis Reveals that the Cytokine IL-17F Forms a Homodimeric Complex with Receptor IL-17RC to Drive IL-17RA-Independent Signaling.
Goepfert A; Lehmann S; Blank J; Kolbinger F; Rondeau JM
Immunity; 2020 Mar; 52(3):499-512.e5. PubMed ID: 32187518
[TBL] [Abstract][Full Text] [Related]
7. The human IL-17A/F heterodimer: a two-faced cytokine with unique receptor recognition properties.
Goepfert A; Lehmann S; Wirth E; Rondeau JM
Sci Rep; 2017 Aug; 7(1):8906. PubMed ID: 28827714
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-17F signaling requires ubiquitination of interleukin-17 receptor via TRAF6.
Rong Z; Cheng L; Ren Y; Li Z; Li Y; Li X; Li H; Fu XY; Chang Z
Cell Signal; 2007 Jul; 19(7):1514-20. PubMed ID: 17346928
[TBL] [Abstract][Full Text] [Related]
9. ABD-Derived Protein Blockers of Human IL-17 Receptor A as Non-IgG Alternatives for Modulation of IL-17-Dependent Pro-Inflammatory Axis.
Hlavničková M; Kuchař M; Osička R; Vaňková L; Petroková H; Malý M; Černý J; Arenberger P; Malý P
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30304852
[TBL] [Abstract][Full Text] [Related]
10. Antagonistic RNA aptamer specific to a heterodimeric form of human interleukin-17A/F.
Adachi H; Ishiguro A; Hamada M; Sakota E; Asai K; Nakamura Y
Biochimie; 2011 Jul; 93(7):1081-8. PubMed ID: 21524680
[TBL] [Abstract][Full Text] [Related]
11. Structural Insights into the Interleukin-17 Family Cytokines and Their Receptors.
Liu S
Adv Exp Med Biol; 2019; 1172():97-117. PubMed ID: 31628653
[TBL] [Abstract][Full Text] [Related]
12. Structural basis of receptor sharing by interleukin 17 cytokines.
Ely LK; Fischer S; Garcia KC
Nat Immunol; 2009 Dec; 10(12):1245-51. PubMed ID: 19838198
[TBL] [Abstract][Full Text] [Related]
13. Conformational dynamics in interleukin 17A and 17F functional complexes is a key determinant of receptor A affinity and specificity.
Waters LC; Veverka V; Strong SL; Muskett FW; Dedi N; Lawson ADG; Prosser CE; Taylor RJ; Henry AJ; Carr MD
Cytokine; 2021 Jun; 142():155476. PubMed ID: 33706174
[TBL] [Abstract][Full Text] [Related]
14. SELEX-discovered aptamer that inhibits cellular interleukin-17/interleukin-17 receptor interaction and antagonizes interleukin-17 signaling.
Munshi AR; Wang T; Takamori Y; Ando T; Yokoyama T; Fuji D; Xu Z; Vedi S; Yamamoto M; Tsukamoto K; Kawakami T
Biosci Biotechnol Biochem; 2024 Jan; 88(2):147-153. PubMed ID: 38031342
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis.
Wang K; Kim MK; Di Caro G; Wong J; Shalapour S; Wan J; Zhang W; Zhong Z; Sanchez-Lopez E; Wu LW; Taniguchi K; Feng Y; Fearon E; Grivennikov SI; Karin M
Immunity; 2014 Dec; 41(6):1052-63. PubMed ID: 25526314
[TBL] [Abstract][Full Text] [Related]
16. Chosen IL-17 family proteins in neutrophils of patients with oral inflammation.
Garley M; Jablonska E
Adv Med Sci; 2008; 53(2):326-30. PubMed ID: 19095584
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin.
Johansen C; Usher PA; Kjellerup RB; Lundsgaard D; Iversen L; Kragballe K
Br J Dermatol; 2009 Feb; 160(2):319-24. PubMed ID: 19016708
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-17A in lipid metabolism and atherosclerosis.
Yu XH; Jiang N; Zheng XL; Cayabyab FS; Tang ZB; Tang CK
Clin Chim Acta; 2014 Apr; 431():33-9. PubMed ID: 24508995
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel immunopharmacological ligands targeting the IL-17 inflammatory pathway.
Álvarez-Coiradas E; Munteanu CR; Díaz-Sáez L; Pazos A; Huber KVM; Loza MI; Domínguez E
Int Immunopharmacol; 2020 Dec; 89(Pt A):107026. PubMed ID: 33045560
[TBL] [Abstract][Full Text] [Related]
20. IL-17A and IL-17F stimulate chemokines via MAPK pathways (ERK1/2 and p38 but not JNK) in mouse cultured mesangial cells: synergy with TNF-alpha and IL-1beta.
Iyoda M; Shibata T; Kawaguchi M; Hizawa N; Yamaoka T; Kokubu F; Akizawa T
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F779-87. PubMed ID: 20042461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
